Hi, I am Xiaodong Feng, My LiveDNA is 86.6297
 
   
  Home
 
 
 
Dr. Xiaodong Feng
 
Highest Degree: Ph.D. in Molecular Biology and Physiology from Chinese Academy of Medical Sciences, China
 
Institute: California Northstate University College of Pharmacy, USA
 
Area of Interest: Molecular Sciences
  •   Cell Biology
  •   Cardiovascular Pharmacology
  •   Immunology
  •   Investigative Dermatology
 
URL: http://livedna.org/86.6297
 
My SELECTED Publications
1:   Feng, X., A. Cai, K. Dong, W. Chaing and M. Feng et al., 2013. Assessing pancreatic cancer risk associated with Dipeptidyl Peptidase 4 inhibitors: Data mining of FDA adverse event reporting system (FAERS). J. Pharmacovigilance, Vol. 1. 10.4172/2329-6887.1000110.
CrossRef  |  Direct Link  |  
2:   Feng, X., B. Brazill and D. Pearson, 2011. Therapeutic application of pharmacogenomics in oncology: Selective biomarkers for cancer treatment. US Pharmacist, 36: 5-12.
3:   Feng, X., D. Vyas and B. Guan, 2012. Novel immune and target therapy for skin cancer. US Pharmacist, 37: 7-11.
4:   Feng, X., K. Dong, D. Pham, S. Pence, J. Inciardi and N.S. Bhutada, 2013. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: A meta-analysis. J. Clin. Pharm. Ther. (In Press). 10.1111/jcpt.12061.
CrossRef  |  
5:   Feng, X., M. Tonnesen, S.A. Mousa and R.A. Clark, 2013. Fibrin and collagen differentially but synergistically regulate sprout angiogenesis of human dermal microvascular endothelial cells in 3-dimensional matrix. Int J Cell Biol. 10.1155/2013/231279.
CrossRef  |  Direct Link  |  
6:   Feng, X., M.G. Tonnesen, E.I. Peerschke and B. Ghebrehiwet, 2002. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J. Immunol., 168: 2441-2448.
PubMed  |  
7:   Feng, X., R.A.F. Clark, D. Galanakis, M.G. Tonnesen, 1999. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: Stablization of αv/β3 mRNA by fibrin. J. Invest. Derm., 113: 913-919.
PubMed  |  
8:   Feng, X., W. Ofstad and D. Hawkins, 2010. Antiangiogenesis therapy: A new strategy for cancer treatment. US Pharmacist, 35: 4-9.
9:   Feng, X., Y. Cai, K.E. Dawes and G.J. Laurent, 1997. Study on chemotaxis and DNA synthesis of pulmonary artery smooth muscle cells. Zhonghua Jie He He Hu Xi Za Zhi, 20: 80-83.
PubMed  |  
10:   Ghebrehiwet, B., B.L. Lim, R. Kumar, X. Feng and E.I.B. Peerschke, 2001. GCiq/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev., 180: 129-141.
11:   Ghebrehiwet, B., X. Feng, R. Kumar and E.I. Peerschke, 2003. Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and integrins. Int. Immunopharmacol., 3: 299-310.
PubMed  |  
12:   Mousa, S.A., F.B. Davis, S. Mohamed, P.J. Davis and X. Feng, 2006. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int. Angiol., 25: 407-413.
Direct Link  |  
13:   Mousa, S.A., X. Feng, J. Xie, Y. Du and Y. Hua et al., 2006. Synthetic oligosaccharide stimulates and stabilizes angiogenesis: Structure-function relationships and potential mechanisms. J. Cardiovasc Pharmacol., 48: 6-13.
PubMed  |  
14:   Tonnesen, M.G., X. Feng and R.A. Clark, 2000. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc., 5: 40-46.
PubMed  |